• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of sodium pentosan polysulphate on tissue lipids in control and glycollate treated rats.

作者信息

Subha K, Varalakshmi P

机构信息

Department of Medical Biochemistry, Dr. A. L. Mudaliar Post Graduate Institute of Basic Medical Sciences, Taramani, University of Madras, India.

出版信息

Pharmacol Res. 1993 May-Jun;27(4):289-97. doi: 10.1006/phrs.1993.1029.

DOI:10.1006/phrs.1993.1029
PMID:7690133
Abstract

Sodium pentosan polysulphate (SPP) has been reported to have a lipid lowering action. In addition it has been shown to prevent calcium oxalate crystallization in vitro and in vivo. Hence it was felt worthwhile to study the effect of SPP on altered tissue lipid levels, manifested in hyperoxaluric condition during glycollate feeding in rats. Elevated cholesterol with reduced phospholipid levels in both liver and kidney tissues, were the significant observations in the experimental animals. In addition total lipids were increased in the kidney. Administration of SPP to hyperoxaluric rats reduced tissue cholesterol and triglyceride levels significantly and raised the phospholipid levels in the tissues. Cholesterol ester synthetase (CES) and cholesterol ester hydrolase (CEH) activities were also assayed in the liver. Glycollate fed rats exhibited increased CES activity. SPP treatment had a lowering effect on CES but enhanced the CEH activity in both control and glycollate administered rats. The alterations may have a bearing in relation to calcium oxalate stone formation.

摘要

相似文献

1
Effect of sodium pentosan polysulphate on tissue lipids in control and glycollate treated rats.
Pharmacol Res. 1993 May-Jun;27(4):289-97. doi: 10.1006/phrs.1993.1029.
2
Changes in serum lipids and lipoproteins in calcium oxalate stone forming rats treated with sodium pentosan polysulphate.
Biochem Int. 1992 Sep;27(6):1011-8.
3
The preventive effect of sodium pentosan polysulfate against renal stone formation in hyperoxaluric rats.戊聚糖多硫酸酯钠对高草酸尿症大鼠肾结石形成的预防作用。
Urol Res. 2002 Oct;30(5):329-35. doi: 10.1007/s00240-002-0271-4. Epub 2002 Aug 15.
4
Alterations in some risk factors and urinary enzymes in urolithiatic rats treated with sodium pentosan polysulphate.用戊聚糖多硫酸钠治疗的尿石症大鼠某些危险因素和尿酶的变化。
Biochem Mol Biol Int. 1993 Feb;29(2):271-80.
5
Effect of DL alpha-lipoic acid on tissue lipid peroxidation and antioxidant systems in normal and glycollate treated rats.DL-α-硫辛酸对正常及乙醇酸处理大鼠组织脂质过氧化和抗氧化系统的影响。
Pharmacol Res. 1993 May-Jun;27(4):309-18. doi: 10.1006/phrs.1993.1031.
6
Sodium pentosan polysulphate--a novel inhibitor of urinary risk factors and enzymes in experimental urolithiatic rats.戊聚糖多硫酸酯钠——实验性尿路结石大鼠尿液风险因素和酶的新型抑制剂
Ren Fail. 1998 Jul;20(4):573-80. doi: 10.3109/08860229809045149.
7
Biochemical changes in kidneys of normal and stone forming rats with sodium pentosan polysulphate.
Biochem Int. 1992 Feb;26(2):357-65.
8
Tissue lipids in experimental calcium oxalate lithiasis and the effect of DL alpha-lipoic acid.
Biochem Int. 1992 Apr;26(5):913-21.
9
[Studies of sodium pentosan polysulphate (SPP) therapy on the urinary stone disease. Experimental studies on the calcium oxalate crystallization and the effects in healthy subjects].[戊聚糖多硫酸钠(SPP)治疗尿路结石病的研究。草酸钙结晶的实验研究及对健康受试者的影响]
Nihon Hinyokika Gakkai Zasshi. 1991 Feb;82(2):246-53. doi: 10.5980/jpnjurol1989.82.246.
10
Nephrocalcinosis and hyperlipidemia in rats fed a cholesterol- and fat-rich diet: association with hyperoxaluria, altered kidney and bone minerals, and renal tissue phospholipid-calcium interaction.喂食富含胆固醇和脂肪饮食的大鼠的肾钙质沉着症和高脂血症:与高草酸尿症、肾脏和骨骼矿物质改变以及肾组织磷脂 - 钙相互作用的关联。
Urol Res. 2000 Dec;28(6):404-15. doi: 10.1007/s002400000144.

引用本文的文献

1
Efficacy and safety of pentosan polysulfate sodium in people with symptomatic knee osteoarthritis and dyslipidaemia: protocol of the MaRVeL trial.戊聚糖多硫酸钠盐治疗膝骨关节炎合并血脂异常患者的疗效和安全性:MaRVeL 试验方案。
BMJ Open. 2024 May 22;14(5):e083046. doi: 10.1136/bmjopen-2023-083046.
2
Pentosan Polysulfate Affords Pleotropic Protection to Multiple Cells and Tissues.聚硫酸戊聚糖对多种细胞和组织具有多向性保护作用。
Pharmaceuticals (Basel). 2023 Mar 13;16(3):437. doi: 10.3390/ph16030437.
3
The effect of pentosan polysulfate sodium for improving dyslipidaemia and knee pain in people with knee osteoarthritis: A pilot study.
戊聚糖多硫酸酯钠对改善膝骨关节炎患者血脂异常和膝关节疼痛的作用:一项初步研究。
Osteoarthr Cartil Open. 2023 Feb 7;5(2):100343. doi: 10.1016/j.ocarto.2023.100343. eCollection 2023 Jun.